United States · Venture startup
5 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$13Mraised across 5 rounds since 2010, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $6.5M sold, first sale May 2025
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Apr 2014
No investor was named in the report.
Reported by sec.govSEC filing: $1.6M sold, first sale Aug 2011
Life Sciences Greenhouse InvestmentsFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Angel Invest
Keiretsu ForumLife Sciences Greenhouse InvestmentsThe Trisiras Group
Mid Atlantic Bio AngelsMinority Angel Investor NetworkMissing a round, or an investor who was in one? Tell us.
Immunomic Therapeutics's investors include Angel Invest, Keiretsu Forum, Life Sciences Greenhouse Investments, The Trisiras Group and Mid Atlantic Bio Angels, and 1 more on record.
Immunomic Therapeutics has raised $13M across 5 rounds since 2010.
Immunomic Therapeutics's most recent round was a Venture of $6.5M in Jun 2025.
Its most recent round, $6.5M in Jun 2025, is also its largest on record.
Immunomic Therapeutics's first round on record, in Mar 2010, was backed by Life Sciences Greenhouse Investments, The Trisiras Group and Minority Angel Investor Network.
Immunomic Therapeutics's latest named round is a Venture, in Jun 2025.
Immunomic Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
